Literature DB >> 22199819

N,N'-Bis(1,3-thia-zol-2-yl)methyl-ene-diamine.

Farshid Salimi, Hajar Sahebalzamani, Masume Maleki, Behrouz Notash.   

Abstract

In the title compound, C(7)H(8)N(4)S(2), the dihedral angle between the thia-zoline rings is 71.25 (13)°. In the crystal, inter-molecular N-H⋯N hydrogen bonds connect the mol-ecules into zigzag chains parallel to the ab plane.

Entities:  

Year:  2011        PMID: 22199819      PMCID: PMC3238970          DOI: 10.1107/S1600536811047659

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For applications of thia­zole compounds see: Raman et al. (2000 ▶); Karimian (2009 ▶); Shi et al. (1996 ▶). For related structures containing an amino­thia­zole moiety, see: Odabaşoğlu & Büyükgüngör, (2006 ▶); Zhao et al. (2006 ▶).

Experimental

Crystal data

C7H8N4S2 M = 212.31 Monoclinic, a = 7.8598 (16) Å b = 8.9291 (18) Å c = 13.672 (3) Å β = 96.39 (3)° V = 953.6 (3) Å3 Z = 4 Mo Kα radiation μ = 0.52 mm−1 T = 298 K 0.45 × 0.35 × 0.3 mm

Data collection

Stoe IPDS 2T diffractometer 7352 measured reflections 2551 independent reflections 1544 reflections with I > 2σ(I) R int = 0.055

Refinement

R[F 2 > 2σ(F 2)] = 0.059 wR(F 2) = 0.162 S = 1.10 2551 reflections 126 parameters 2 restraints H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.35 e Å−3 Δρmin = −0.33 e Å−3 Data collection: X-AREA (Stoe & Cie, 2005 ▶); cell refinement: X-AREA; data reduction: X-RED; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶). Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536811047659/bt5707sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811047659/bt5707Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811047659/bt5707Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C7H8N4S2F(000) = 440
Mr = 212.31Dx = 1.479 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ynCell parameters from 2551 reflections
a = 7.8598 (16) Åθ = 2.9–29.2°
b = 8.9291 (18) ŵ = 0.52 mm1
c = 13.672 (3) ÅT = 298 K
β = 96.39 (3)°Block, colorless
V = 953.6 (3) Å30.45 × 0.35 × 0.3 mm
Z = 4
Stoe IPDS 2T diffractometer1544 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.055
graphiteθmax = 29.2°, θmin = 2.9°
Detector resolution: 0.15 mm pixels mm-1h = −10→10
rotation method scansk = −10→12
7352 measured reflectionsl = −18→16
2551 independent reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.059Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.162H atoms treated by a mixture of independent and constrained refinement
S = 1.10w = 1/[σ2(Fo2) + (0.0781P)2] where P = (Fo2 + 2Fc2)/3
2551 reflections(Δ/σ)max < 0.001
126 parametersΔρmax = 0.35 e Å3
2 restraintsΔρmin = −0.33 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
S10.17187 (10)0.85527 (11)0.66273 (7)0.0600 (3)
S20.38487 (10)0.58898 (11)0.36382 (7)0.0638 (3)
N20.2786 (3)0.9024 (3)0.4824 (2)0.0534 (7)
N30.1223 (3)0.6689 (3)0.4651 (2)0.0517 (7)
N40.1924 (3)0.4157 (3)0.4539 (2)0.0503 (6)
C10.3071 (4)0.9249 (3)0.5804 (2)0.0458 (7)
C50.2187 (3)0.5568 (3)0.4343 (2)0.0445 (6)
N10.4391 (3)0.9984 (3)0.6235 (2)0.0540 (7)
C30.4335 (4)1.0032 (4)0.7244 (3)0.0609 (9)
H30.51771.05210.76580.073*
C40.1332 (4)0.8213 (4)0.4347 (3)0.0543 (8)
H4A0.02940.87270.44760.065*
H4B0.13860.82340.36420.065*
C60.3067 (4)0.3273 (4)0.4103 (3)0.0596 (9)
H60.30660.22360.41610.072*
C20.3025 (4)0.9349 (5)0.7596 (3)0.0663 (10)
H20.28410.93060.82550.080*
C70.4177 (4)0.3987 (4)0.3592 (3)0.0637 (9)
H70.50040.35230.32610.076*
H3A0.031 (3)0.645 (4)0.489 (2)0.053 (9)*
H2A0.358 (4)0.924 (5)0.447 (3)0.084 (13)*
U11U22U33U12U13U23
S10.0549 (4)0.0643 (6)0.0650 (5)−0.0030 (4)0.0247 (4)0.0069 (4)
S20.0533 (5)0.0637 (6)0.0801 (6)−0.0071 (4)0.0333 (4)−0.0008 (5)
N20.0617 (15)0.0475 (16)0.0529 (16)−0.0179 (12)0.0145 (12)0.0007 (12)
N30.0445 (13)0.0392 (15)0.0749 (18)−0.0073 (10)0.0228 (12)−0.0046 (12)
N40.0464 (13)0.0423 (15)0.0648 (17)−0.0020 (10)0.0173 (11)0.0001 (12)
C10.0502 (15)0.0326 (15)0.0568 (18)0.0012 (11)0.0156 (13)0.0033 (13)
C50.0365 (12)0.0482 (17)0.0498 (16)−0.0050 (11)0.0098 (11)−0.0066 (14)
N10.0539 (15)0.0482 (16)0.0615 (16)−0.0081 (11)0.0131 (12)−0.0041 (13)
C30.0624 (19)0.066 (2)0.0543 (19)0.0030 (16)0.0080 (15)−0.0124 (16)
C40.0527 (16)0.0458 (18)0.065 (2)−0.0034 (13)0.0072 (14)0.0001 (15)
C60.0561 (16)0.0466 (19)0.078 (2)0.0090 (14)0.0169 (15)−0.0049 (17)
C20.067 (2)0.084 (3)0.0508 (19)0.0105 (18)0.0172 (16)−0.0026 (18)
C70.0522 (17)0.067 (2)0.075 (2)0.0116 (15)0.0218 (16)−0.0061 (18)
S1—C21.735 (4)N4—C61.380 (4)
S1—C11.746 (3)C1—N11.311 (4)
S2—C71.721 (4)N1—C31.385 (5)
S2—C51.731 (3)C3—C21.332 (5)
N2—C11.349 (4)C3—H30.9300
N2—C41.446 (4)C4—H4A0.9700
N2—H2A0.850 (19)C4—H4B0.9700
N3—C51.351 (4)C6—C71.338 (5)
N3—C41.428 (4)C6—H60.9300
N3—H3A0.850 (18)C2—H20.9300
N4—C51.309 (4)C7—H70.9300
C2—S1—C189.70 (17)C2—C3—H3121.4
C7—S2—C588.96 (16)N1—C3—H3121.4
C1—N2—C4123.9 (3)N3—C4—N2114.6 (3)
C1—N2—H2A118 (3)N3—C4—H4A108.6
C4—N2—H2A117 (3)N2—C4—H4A108.6
C5—N3—C4124.1 (3)N3—C4—H4B108.6
C5—N3—H3A117 (2)N2—C4—H4B108.6
C4—N3—H3A116 (2)H4A—C4—H4B107.6
C5—N4—C6109.7 (3)C7—C6—N4116.5 (3)
N1—C1—N2123.8 (3)C7—C6—H6121.7
N1—C1—S1113.4 (2)N4—C6—H6121.7
N2—C1—S1122.8 (2)C3—C2—S1109.1 (3)
N4—C5—N3122.8 (2)C3—C2—H2125.4
N4—C5—S2114.8 (2)S1—C2—H2125.4
N3—C5—S2122.3 (2)C6—C7—S2110.0 (2)
C1—N1—C3110.6 (3)C6—C7—H7125.0
C2—C3—N1117.2 (3)S2—C7—H7125.0
C4—N2—C1—N1179.9 (3)N2—C1—N1—C3179.9 (3)
C4—N2—C1—S11.1 (4)S1—C1—N1—C3−1.1 (3)
C2—S1—C1—N11.1 (3)C1—N1—C3—C20.5 (5)
C2—S1—C1—N2−179.9 (3)C5—N3—C4—N2−77.4 (4)
C6—N4—C5—N3178.0 (3)C1—N2—C4—N3−60.5 (4)
C6—N4—C5—S2−0.9 (4)C5—N4—C6—C70.3 (5)
C4—N3—C5—N4−171.6 (3)N1—C3—C2—S10.3 (4)
C4—N3—C5—S27.2 (5)C1—S1—C2—C3−0.8 (3)
C7—S2—C5—N41.0 (3)N4—C6—C7—S20.4 (5)
C7—S2—C5—N3−177.9 (3)C5—S2—C7—C6−0.8 (3)
D—H···AD—HH···AD···AD—H···A
N2—H2A···N1i0.85 (2)2.07 (2)2.918 (4)171 (4)
N3—H3A···N4ii0.85 (2)2.07 (2)2.919 (3)179 (4)
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N2—H2A⋯N1i0.85 (2)2.07 (2)2.918 (4)171 (4)
N3—H3A⋯N4ii0.85 (2)2.07 (2)2.919 (3)179 (4)

Symmetry codes: (i) ; (ii) .

  4 in total

1.  Titanium(IV)-mediated tandem deprotection-cyclodehydration of protected cysteine N-amides: biomimetic syntheses of thiazoline- and thiazole-containing heterocycles.

Authors:  P Raman; H Razavi; J W Kelly
Journal:  Org Lett       Date:  2000-10-19       Impact factor: 6.005

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.

Authors:  D F Shi; T D Bradshaw; S Wrigley; C J McCall; P Lelieveld; I Fichtner; M F Stevens
Journal:  J Med Chem       Date:  1996-08-16       Impact factor: 7.446

4.  Imidazo[2,1-b]thiazoles and their use as pharmaceuticals: Sanofi-Aventis EP 1 923 062 A1 (equivalent to WO2008058641).

Authors:  K Karimian
Journal:  Expert Opin Ther Pat       Date:  2009-03       Impact factor: 6.674

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.